3-128481845-A-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000341105.7(GATA2):c.1117T>C(p.Cys373Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C373Y) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000341105.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATA2 | NM_001145661.2 | c.1117T>C | p.Cys373Arg | missense_variant | 6/7 | ENST00000487848.6 | NP_001139133.1 | |
GATA2 | NM_032638.5 | c.1117T>C | p.Cys373Arg | missense_variant | 5/6 | ENST00000341105.7 | NP_116027.2 | |
GATA2 | NM_001145662.1 | c.1075T>C | p.Cys359Arg | missense_variant | 5/6 | NP_001139134.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATA2 | ENST00000341105.7 | c.1117T>C | p.Cys373Arg | missense_variant | 5/6 | 1 | NM_032638.5 | ENSP00000345681 | P1 | |
GATA2 | ENST00000487848.6 | c.1117T>C | p.Cys373Arg | missense_variant | 6/7 | 1 | NM_001145661.2 | ENSP00000417074 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Jul 02, 2021 | GATA2 c.1117T>C has been previously reported in a patient with Emberger syndrome. This GATA2 variant is absent from a large population dataset but has been reported in ClinVar (Variation ID:29720 ). p.Cys373Arg is predicted to alter one of the invariant zinc-coordinating cysteine residues in the second C4 zinc-finger domain of GATA2. In vitro functional studies indicate that p.Cys373Arg impacts the function of GATA2 by altering its interaction with the hematopoietic differentiation factor PU.1 and reducing its transactivation activity and DNA binding affinity. We consider GATA2 c.1117T>C to be likely pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 04, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 21892158, 1714909, 28179282, 21956389, 26214525, 37580379, 28642594, 34387894, 31785092, 33038986, 29906059, 22147895, 35753998, 20803646) - |
Deafness-lymphedema-leukemia syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 04, 2011 | - - |
Deafness-lymphedema-leukemia syndrome;CN300066:GATA2 deficiency with susceptibility to MDS/AML Pathogenic:1
Likely pathogenic, criteria provided, single submitter | curation | Molecular Pathology Research Laboratory, SA Pathology | Jul 06, 2021 | PS3_Supporting, PS4_Supporting, PM1, PM2, PM5, PP3 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at